Tom Santamaria

China Medicine Investors Pleased with 2008 Numbers

This is like many Chinese micro-caps very undervalued when one considers that along with $.60 fully diluted eps investors also get a company with very little debt & a current accounts ratio that shows Assets far outstrip liabilities.

But enough about current information, What about the future? That future is ADTZ & plain & simple the potential of ADTZ far outstrips anything CHME has done in the past.